Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» immuno-oncology
immuno-oncology
Astellas pumps $90m into Sutro immuno-oncology alliance
Pharmaforum
Tue, 06/28/22 - 10:35 am
Astellas
Sutro BioPharma
antibody-drug conjugate
cancer
immuno-oncology
Pfizer-Backed DEM Bio Launches to Leverage CRISPR in Immuno-Oncology
BioSpace
Thu, 06/23/22 - 10:42 am
DEM BioPharma
CRISPR
immuno-oncology
Pfizer
Exelixis taps into cancer antibody discoverer out of Sweden
Endpoints
Thu, 06/16/22 - 10:28 am
Exelixis
Bioinvent
cancer
Sweden
immuno-oncology
GO! Astellas picks up partner in convertibleCAR for backloaded $780M antibody project
Fierce Biotech
Wed, 06/1/22 - 09:53 am
Astellas
immuno-oncology
R&D
Go Therapeutics
glycoprotein targets
Merck snaps up cancer drug from China’s Kelun in $1.4bn deal
Pharmaforum
Wed, 05/18/22 - 11:53 pm
Merck
immuno-oncology
China
Sichuan Kelun Pharmaceutical
Silverback falls on hard times, axing lead I/O candidates and laying off more than a fourth of staff
Endpoints
Fri, 04/1/22 - 10:35 am
Silverback Theraepeutics
cancer
immuno-oncology
layoffs
BioNTech and Crescendo Biologics team up to develop multi-specific precision immunotherapies
Biopharma Reporter
Tue, 01/11/22 - 11:34 am
BioNTech
Crescendo Biologics
immuno-oncology
R&D
Sanofi buys US immuno-oncology biotech Amunix for $1 billion
Pharmaforum
Tue, 12/21/21 - 10:36 am
Sanofi
M&A
Amunix
immuno-oncology
cancer
solid tumors
oncology
Immuno-oncology spotlight falls on cervical cancer
EP Vantage
Tue, 12/7/21 - 10:39 am
immuno-oncology
cervical cancer
Opdivo
Keytruda
Bristol Myers Squibb
Merck
Pfizer acquires Trillium Therapeutics for $2.22bn
Pharmaceutical Business Review
Thu, 11/18/21 - 10:32 am
Pfizer
Trillium Therapeutics
M&A
immuno-oncology
Oncotelic Hopes to Leverage Intranasal Apomorphine to Treat Parkinson’s Disease
BioSpace
Mon, 10/4/21 - 10:57 pm
Oncotelic
immuno-oncology
RNA
small molecule drugs
Parkinson's Disease
erectile dysfunction
Elixiron closes $27M series A for Alzheimer's and vitiligo clinical trials
Fierce Biotech
Mon, 08/23/21 - 11:18 pm
Elixiron Immunotherapeutics
funding
Alzheimer's disease
immuno-oncology
Pfizer to acquire immuno-oncology company Trillium
Biopharma Reporter
Mon, 08/23/21 - 11:59 am
Pfizer
Trillium Therapeutics
M&A
immuno-oncology
Eli Lilly hands Kumquat Biosciences $70M to kick off cancer drug R&D alliance
MedCity News
Thu, 07/29/21 - 11:03 am
Eli Lilly
Kumquat Biosciences
R&D
immuno-oncology
cancer
Digital tools key to immuno-oncology’s future: report
Pharmaforum
Sun, 07/25/21 - 11:49 am
digital pharma
immuno-oncology
ASCO 2021
A pair of former MIT researchers think they've unlocked the next generation of mRNA using synbio 'logic circuits'
Endpoints
Wed, 06/23/21 - 10:58 am
Strand Therapeutics
funding
MRNA
solid tumors
immuno-oncology
MIT
GSK pays iTeos $625M upfront to join Merck, Roche and the rest in TIGIT immuno-oncology race
Fierce Biotech
Mon, 06/14/21 - 10:17 am
GSK
iTeos Therapeutics
EOS-448
immuno-oncology
ASCO: Boehringer, OSE offer promising glimpse of the immuno-oncology drug at the heart of their $1.4B deal
Fierce Biotech
Fri, 05/21/21 - 11:52 am
Boehringer Ingelheim
OSE Immunotherapeutics
immuno-oncology
BI 765063
ASCO 2021
Merck KGaA lands rights to 3rd F-star oncology bispecific antibody
Fierce Biotech
Fri, 04/2/21 - 10:46 am
Merck KGaA
F-star Therapeutics
immuno-oncology
bispecific antibodies
As Alkermes shines light on early cancer, neuro assets, biotech searches for collabs, strategic ops
Fierce Biotech
Fri, 03/26/21 - 10:47 am
Alkermes
R&D
cancer
immuno-oncology
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »